دورية أكاديمية

Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial.

التفاصيل البيبلوغرافية
العنوان: Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial.
المؤلفون: Parekh, Dhruv, Dancer, Rachel C A, Lax, Sian, Cooper, Mark S, Martineau, Adrian R, Fraser, William D, Tucker, Olga, Alderson, Derek, Perkins, Gavin D, Gao-Smith, Fang, Thickett, David R
المصدر: Trials; 2013, Vol. 14 Issue 1, p100-100, 1p
مصطلحات موضوعية: ARTIFICIAL respiration, COMPARATIVE studies, DIGESTIVE organ surgery, DRUG administration, EXPERIMENTAL design, LUNG injuries, RESEARCH methodology, MEDICAL cooperation, RESEARCH protocols, ORAL drug administration, PULMONARY edema, RESEARCH, RESEARCH funding, ELECTIVE surgery, TIME, VITAMIN D, EVALUATION research, RANDOMIZED controlled trials, TREATMENT effectiveness, BLIND experiment, ACUTE diseases, PREVENTION
مصطلحات جغرافية: UNITED Kingdom
مستخلص: Background: Acute lung injury occurs in approximately 25% to 30% of subjects undergoing oesophagectomy. Experimental studies suggest that treatment with vitamin D may prevent the development of acute lung injury by decreasing inflammatory cytokine release, enhancing lung epithelial repair and protecting alveolar capillary barrier function.Methods/design: The 'Vitamin D to prevent lung injury following oesophagectomy trial' is a multi-centre, randomised, double-blind, placebo-controlled trial. The aim of the trial is to determine in patients undergoing elective transthoracic oesophagectomy, if pre-treatment with a single oral dose of vitamin D3 (300,000 IU (7.5 mg) cholecalciferol in oily solution administered seven days pre-operatively) compared to placebo affects biomarkers of early acute lung injury and other clinical outcomes. The primary outcome will be change in extravascular lung water index measured by PiCCO® transpulmonary thermodilution catheter at the end of the oesophagectomy. The trial secondary outcomes are clinical markers indicative of lung injury: PaO2:FiO2 ratio, oxygenation index; development of acute lung injury to day 28; duration of ventilation and organ failure; survival; safety and tolerability of vitamin D supplementation; plasma indices of endothelial and alveolar epithelial function/injury, plasma inflammatory response and plasma vitamin D status. The study aims to recruit 80 patients from three UK centres.Discussion: This study will ascertain whether vitamin D replacement alters biomarkers of lung damage following oesophagectomy.Trial Registration: Current Controlled Trials ISRCTN27673620. [ABSTRACT FROM AUTHOR]
Copyright of Trials is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17456215
DOI:10.1186/1745-6215-14-100